Jan Bergman

10.2k total citations · 1 hit paper
254 papers, 7.9k citations indexed

About

Jan Bergman is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Jan Bergman has authored 254 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Organic Chemistry, 72 papers in Molecular Biology and 39 papers in Toxicology. Recurrent topics in Jan Bergman's work include Synthesis and Biological Evaluation (48 papers), Synthesis of Indole Derivatives (39 papers) and Quinazolinone synthesis and applications (23 papers). Jan Bergman is often cited by papers focused on Synthesis and Biological Evaluation (48 papers), Synthesis of Indole Derivatives (39 papers) and Quinazolinone synthesis and applications (23 papers). Jan Bergman collaborates with scholars based in Sweden, United States and Finland. Jan Bergman's co-authors include Vladimir J.N. Bykov, Klas G. Wiman, Anette Witt, Lennart Venemalm, Tomasz Janosik, Galina Selivanova, Natalia Issaeva, Monica Hultcrantz, Benjamin Pelcman and Peter M. Chumakov and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jan Bergman

240 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

2002 840 citations Vladimir J.N. Bykov, Natalia Issaeva et al. Nature Medicine profile →

Peers

Countries citing papers authored by Jan Bergman

Since Specialization

Citations

This map shows the geographic impact of Jan Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Bergman more than expected).

Fields of papers citing papers by Jan Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Bergman. The network helps show where Jan Bergman may publish in the future.

Co-authorship network of co-authors of Jan Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Bergman. A scholar is included among the top collaborators of Jan Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Bergman. Jan Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Thiol Reactivity for Targeting Mutant p53 2018 ·Cell chemical biology ·Qiang Zhang, Jan Bergman, Klas G. Wiman, Vladimir J.N. Bykov	17
2	Synthesis of A New Intercalating Nucleic Acid 6H-INDOLO[2,3-b] Quinoxaline Oligonucleotides to Improve Thermal Stability Of Hoogsteen-Type Triplexes 2013 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown), Erik B. Pedersen, Jan Bergman	6
3	PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain 2009 ·Cancer Cell ·Jérémy Lambert, (unknown), Dmitry B. Veprintsev, (unknown), Dan Segerbäck, Jan Bergman, Alan R. Fersht, Pierre Hainaut, Klas G. Wiman, Vladimir J.N. Bykov	450
4	Mutant p53 targeting by the low molecular weight compound STIMA‐1 2008 ·Molecular Oncology ·Nicole Zache, Jérémy Lambert, (unknown), Jinfeng Shen, Pierre Hainaut, Jan Bergman, Klas G. Wiman, Vladimir J.N. Bykov	95
5	The Suggested Physiologic Aryl Hydrocarbon Receptor Activator and Cytochrome P4501 Substrate 6-Formylindolo[3,2-b]carbazole Is Present in Humans 2008 ·Journal of Biological Chemistry ·Emma Wincent, Nahid Amini, (unknown), Hansruedi Glatt, Jan Bergman, Carlo Crescenzi, Agneta Rannug, Ulf Rannug	231
6	Total synthesis of luotonin A and 14-substituted analogues 2007 ·Organic & Biomolecular Chemistry ·Jeffrey J. Mason, Jan Bergman	29
7	Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs 2005 ·Journal of Biological Chemistry ·Vladimir J.N. Bykov, Natalia Issaeva, Nicole Zache, (unknown), Monica Hultcrantz, Jan Bergman, Galina Selivanova, Klas G. Wiman	193
8	PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis 2005 ·Oncogene ·Vladimir J.N. Bykov, Nicole Zache, Hélène Stridh, Jacob Westman, Jan Bergman, Galina Selivanova, Klas G. Wiman	203
9	Synthesis of some fused β‐carbolines including the first example of the pyrrolo[3,2‐c]‐β‐carboline system 2004 ·Journal of Heterocyclic Chemistry ·(unknown), Jan Bergman	9
10	The influence of intercalator binding on DNA triplex stability: correlation with effects on A‐tract duplex structure 2004 ·Journal of Molecular Recognition ·Karin Sandström, Sebastian K.T.S. Wärmländer, Jan Bergman, (unknown), Mikael Leijon, Astrid Gräslund	18
11	Preparation and evaluation of sulfur-containing metal chelators 2003 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), (unknown), Lars‐Ole Gerlach, Thomas Högberg, Jan Bergman	20
12	Products from dehydration of dicarboxylic acids derived from anthranilic acid 2003 ·Organic & Biomolecular Chemistry ·Per Wiklund, Iván Romero‐Estudillo, Jan Bergman	8
13	Ring forming reactions of imines of 2-aminobenzaldehyde and related compounds 2002 ·Organic & Biomolecular Chemistry ·Per Wiklund, Jan Bergman	24
14	Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound breakdown → 2002 ·Nature Medicine ·Vladimir J.N. Bykov, Natalia Issaeva, (unknown), Monica Hultcrantz, Elena N. Pugacheva, Peter M. Chumakov, Jan Bergman, Klas G. Wiman, Galina Selivanova	840
15	Interactions of the antiviral quinoxaline derivative 9-OH-B220 {2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2,3-b]quinoxaline} with duplex and triplex forms of synthetic DNA and RNA 1998 ·Journal of Molecular Biology ·Ulrica Sehlstedt, Palok Aich, Jan Bergman, Hans Vallberg, Bengt Nordén, Astrid Gräslund	115
16	COUPLING REACTIONS OF 1,2-BIS(2-INDOLYL)ETHANE. FORMATION OF INDOLO[2,3-c]CARBAZOLES 1997 ·Heterocyclic Communications ·Jan Bergman, Eric Desarbre, Tomasz Janosik, (unknown), Lennart Venemalm	4
17	¹H‐NMR studies of the interaction between a self‐complementary deoxyoligonucleotide duplex and indolo[2,3‐b]quinoxaline derivatives active against herpes virus 1991 ·European Journal of Biochemistry ·Naina Patel, Jan Bergman, Astrid Gräslund	33
18	The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline 1991 ·Antiviral Research ·Johan Harmenberg, (unknown), Astrid Gräslund, Torbjörn Malmfors, Jan Bergman, Britta Wahrén, Stig Åkerfeldt, (unknown), Susan Cox	85
19	Effects of Immunosuppressive Chemicals on Lymphoid Development in Foetal Thymus Organ Cultures 1989 ·Pharmacology & Toxicology ·Roland d'Argy, Jan Bergman, Lennart Dencker	13
20	Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver 1989 ·Carcinogenesis ·Mikael Gillner, Jan Bergman, Christian Cambillau, Jan‐Åke Gustafsson	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact